ATE398671T1 - Humane epitheliale zellen von müllerian ductus- abstammende, verfahren zur ihrer isolierung und verwendungen davon - Google Patents

Humane epitheliale zellen von müllerian ductus- abstammende, verfahren zur ihrer isolierung und verwendungen davon

Info

Publication number
ATE398671T1
ATE398671T1 AT01924679T AT01924679T ATE398671T1 AT E398671 T1 ATE398671 T1 AT E398671T1 AT 01924679 T AT01924679 T AT 01924679T AT 01924679 T AT01924679 T AT 01924679T AT E398671 T1 ATE398671 T1 AT E398671T1
Authority
AT
Austria
Prior art keywords
epithelial cells
müllerian
derived epithelial
ductus
isolation
Prior art date
Application number
AT01924679T
Other languages
German (de)
English (en)
Inventor
Ronghao Li
Jennie Mather
Original Assignee
Raven Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raven Biotechnologies Inc filed Critical Raven Biotechnologies Inc
Application granted granted Critical
Publication of ATE398671T1 publication Critical patent/ATE398671T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01924679T 2000-04-07 2001-04-04 Humane epitheliale zellen von müllerian ductus- abstammende, verfahren zur ihrer isolierung und verwendungen davon ATE398671T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/545,435 US6416999B1 (en) 2000-04-07 2000-04-07 Human Müllerian duct-derived epithelial cells and methods of isolation and uses thereof

Publications (1)

Publication Number Publication Date
ATE398671T1 true ATE398671T1 (de) 2008-07-15

Family

ID=24176236

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01924679T ATE398671T1 (de) 2000-04-07 2001-04-04 Humane epitheliale zellen von müllerian ductus- abstammende, verfahren zur ihrer isolierung und verwendungen davon

Country Status (11)

Country Link
US (2) US6416999B1 (https=)
EP (1) EP1276850B1 (https=)
JP (1) JP4748700B2 (https=)
KR (1) KR100748039B1 (https=)
CN (1) CN1423692A (https=)
AT (1) ATE398671T1 (https=)
AU (2) AU2001251311B2 (https=)
CA (1) CA2404634A1 (https=)
DE (1) DE60134469D1 (https=)
DK (1) DK1276850T3 (https=)
WO (1) WO2001077298A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416999B1 (en) * 2000-04-07 2002-07-09 Raven Biotechnologies, Inc. Human Müllerian duct-derived epithelial cells and methods of isolation and uses thereof
CA2475356A1 (en) * 2002-02-12 2003-08-21 Raven Biotechnologies, Inc. Human fetal bladder-derived epithelial cells
US20040045045A1 (en) * 2002-05-30 2004-03-04 Mather Jennie P. Animal model for toxicology and dose prediction
MXPA04012664A (es) * 2002-06-19 2005-08-15 Raven Biotechnologies Inc Objetivo de superficie celular raag10 novedoso y una familia de anticuerpos que reconocen ese objetivo.
WO2004043239A2 (en) * 2002-11-13 2004-05-27 Raven Biotechnologies, Inc. Antigen pipa and antibodies that bind thereto
EP2422802A3 (en) 2006-03-07 2013-03-06 Geeta Shroff Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
KR101523698B1 (ko) * 2007-01-22 2015-05-29 마크로제닉스 웨스트 인코퍼레이티드 사람 암 줄기세포
ES2666152T3 (es) 2009-08-13 2018-05-03 The Johns Hopkins University Métodos de modulación de la función inmunitaria con anticuerpos anti-B7-H7CR
CN102732479B (zh) * 2011-03-31 2014-08-27 北京大学 胸腺上皮前体细胞的制备方法及其专用培养基
AU2013248265B2 (en) * 2012-11-08 2018-11-01 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
CN108061804B (zh) * 2016-11-09 2020-05-12 北京大学人民医院 用于诊断子宫内膜异位症的生物标志物
CN107475369B (zh) * 2017-07-07 2021-05-04 南方医科大学 Hoxa9基因在制备治疗皮肤鳞状细胞癌药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT802257E (pt) * 1996-04-19 2003-01-31 Nestle Sa Linhagem imortalizada de celulas epiteliais do colon humano
US6004528A (en) 1997-09-18 1999-12-21 Bergstein; Ivan Methods of cancer diagnosis and therapy targeted against the cancer stemline
US6416999B1 (en) 2000-04-07 2002-07-09 Raven Biotechnologies, Inc. Human Müllerian duct-derived epithelial cells and methods of isolation and uses thereof

Also Published As

Publication number Publication date
AU5131101A (en) 2001-10-23
DE60134469D1 (de) 2008-07-31
WO2001077298A3 (en) 2002-07-04
CA2404634A1 (en) 2001-10-18
WO2001077298A2 (en) 2001-10-18
KR100748039B1 (ko) 2007-08-09
CN1423692A (zh) 2003-06-11
US6416999B1 (en) 2002-07-09
AU2001251311B2 (en) 2005-03-03
DK1276850T3 (da) 2008-10-13
JP2003530100A (ja) 2003-10-14
US20030040110A1 (en) 2003-02-27
EP1276850A2 (en) 2003-01-22
EP1276850B1 (en) 2008-06-18
US7125713B2 (en) 2006-10-24
JP4748700B2 (ja) 2011-08-17
KR20030032933A (ko) 2003-04-26

Similar Documents

Publication Publication Date Title
ATE348877T1 (de) Humane pankreatische epitheliale stammzellen, verfahren zur ihrer isolierung und verwendungen davon
ATE398671T1 (de) Humane epitheliale zellen von müllerian ductus- abstammende, verfahren zur ihrer isolierung und verwendungen davon
ATE438708T1 (de) Verfahren zur isolierung, expansion und differenzierung fötaler stammzellen aus chorionzotte, fruchtwasser und plazenta und therapeutische verwendungen davon
ATE469219T1 (de) Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen
WO2002083864A3 (en) Methods and reagents for cell transplantation
WO2004090114A3 (en) Compositions and methods of using a synthetic dnase i
EP2722387A3 (en) Definitive endoderm
EP2446892A3 (de) Isolierte adulte pluripotente Stammzellen und Verfahren zu deren Isolierung und Kultivierung
EP2471903A3 (en) Placental stem cell populations
AU2002359522A8 (en) Compositions and methods of selective nucleic acid isolation
AU2002348563A1 (en) Nucleic acid enrichment
ATE407138T1 (de) Verfahren zur herstellung interferierender rna- moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
WO2002033116A3 (en) Nucleic acid ligands to the prostate specific membrane antigen
DE60239741D1 (de) Antigenpräsentierende zellen, verfahren zu ihrer herstellung sowie ihre verwendung für krebsimpfstoffe
DE60138804D1 (de) Verfahren zur herstellung von physiologisch aktiven substanzen enthaltenden dispersionen unter anwendung von hochdruck und hochscherkraft
DE60221224D1 (de) Verfahren und vektoren für die plastiden-transformation von höheren pflanzen
IL161873A0 (en) Production of cell suspensions
WO2005001039A3 (en) Ribozyme-regulated small inhibitory rna (sirna) production and methods of use thereof
WO2003068938A3 (en) Human fetal bladder-derived epithelial cells
WO2003010292A3 (en) Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors
WO2022226020A3 (en) Engineering b cell-based protein factories to treat serious diseases
ATE520770T1 (de) Humane eierstockmesothelialzellen und verfahren zu deren isolierung und verwendung
TW200510011A (en) A method for regeneration of bone
WO2004072262A3 (en) Cultured cd14+ antigen presenting cells
Zhang et al. Active demethylation of individual genes in intracytoplasmic sperm injection rabbit embryos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties